A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

NCT00697255 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovulation Induction

Interventions

DRUG: corifollitropin alfa
BIOLOGICAL: recombinant Follicle Stimulating Hormone (recFSH)
BIOLOGICAL: human Chorion Gonadotropin (hCG)
BIOLOGICAL: hCG Bolus injection

Sponsor

Organon and Co